Home Ethos About Contact Terms Policy Ethicoin RichTVX The U.S. Intelligence Community dni.gov cia.gov nsa.gov dia.mil fbi.gov state.gov dhs.gov dea.gov treasury.gov energy.gov Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease, after months of lobbying by patient advocates urging approval. On March 29, 2022 By admin Breaking News Post navigation Previous PostBiden's $5.8 Trillion Budget Plan: Raise Taxes on Rich, Trim Deficits, Boost Police FundingNext PostJan. 6 Panel Recommends Contempt Charge for Navarro, Scavino